IBM www.ibm.com/watson and the Jupiter Medical Center http://Jupitermed.com in Florida are adopting “Watson for Oncology”, a cognitive computing platform capable of providing insights to physicians to help them deliver personalized evidence-based cancer treatments.
In the U.S, there will be an estimated 1.7 million new cancer cases this year with 125,000 in Florida alone. As healthcare providers and systems seek to enable data-driven, evidence-based cancer care, an explosion of medical information has created both challenges and opportunities to improve quality care.
Watson provides information to oncologists to help them deliver evidence-based treatment options by analyzing massive volumes of medical literature to identify individualized treatment options and scale access to oncology expertise.
Watson draws from more than 300 medical journals, 200 textbooks, and nearly 15 million pages of text to provide insights about different treatment options. Watson also provides information regarding drug options and administration instructions plus ranks the evidence-based treatment options which link to peer reviewed studies and clinical guidelines.
IBM and Memorial Sloan Kettering (MSK) www.mskcc.org have accelerated Watson’s training. “Watson for Oncology” is now available to assist clinicians in developing treatment plans for breast, lung, colorectal, cervical, ovarian, and gastric cancers. IBM and MSK plan to train Watson on at least nine additional cancer types this year, covering nearly 80 percent of the worldwide incidence of cancer.
“At Jupiter Medical Center, we are committed to pioneering new approaches to medicine and healthcare,” said John D. Couris, President and CEO of the Jupiter Medical Center. “Watson for Oncology” is part of our significant investment in creating a world class cancer program and we are proud to be the first U.S. community hospital to arm our clinical teams with this cutting-edge technology.”